Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.41%823.6M | 16.45%889.52M | 5.54%249.71M | 25.11%253.28M | 16.86%210.51M | 21.70%176.02M | 102.18%763.83M | 54.02%236.61M | 175.63%202.45M | 100.60%180.14M |
| Cost of revenue | -31.22%415.36M | 51.30%603.89M | 25.41%144.91M | 87.58%216.31M | 44.27%135.26M | 44.17%107.42M | 132.11%399.13M | 44.29%115.55M | 277.00%115.31M | 177.00%93.76M |
| Gross profit | 42.93%408.24M | -21.68%285.62M | -13.43%104.8M | -57.58%36.96M | -12.89%75.25M | -2.18%68.61M | 77.17%364.7M | 64.61%121.06M | 103.29%87.13M | 54.38%86.38M |
| Operating expense | -15.66%379.57M | 7.96%450.03M | 31.60%117.29M | 4.92%116.35M | -3.77%105.74M | 3.45%110.65M | 86.54%416.86M | 1.92%89.12M | 104.51%110.89M | 183.58%109.89M |
| Operating profit | 117.44%28.67M | -215.21%-164.41M | -139.10%-12.48M | -234.15%-79.38M | -29.71%-30.5M | -14.18%-42.05M | -196.01%-52.16M | 329.68%31.93M | -109.09%-23.76M | -236.68%-23.51M |
| Net non-operating interest income (expenses) | -3,846.43%-4.42M | 34.50%-112K | 79.10%-42K | -293.10%-56K | 80.49%-8K | -114.29%-6K | -114.60%-171K | -182.04%-201K | -85.71%29K | -109.38%-41K |
| Non-operating interest income | -17.65%112K | -82.20%136K | -99.49%1K | --0 | -58.33%60K | -68.49%75K | -41.00%764K | -46.61%197K | -8.87%185K | -67.05%144K |
| Non-operating interest expense | -72.98%67K | -60.94%248K | -56.12%43K | -64.10%56K | -63.24%68K | -58.67%81K | 412.10%635K | -20.97%98K | --156K | --185K |
| Total other finance cost | --4.47M | ---- | ---- | ---- | ---- | ---- | --300K | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 933.33%3.1M | 300K | 0 | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 106.89%11.76M | -70,707.05%-170.65M | -89.58%261K | -16,282.97%-171.2M | -135.03%-4.81M | 1,371.76%5.11M | 98.87%-241K | 127.00%2.5M | 75.02%-1.05M | 62.72%-2.05M |
| Less:Other special charges | ---- | 40,404.07%159.18M | --0 | ---- | ---- | ---- | -88.76%393K | --0 | --0 | ---- |
| Less:Write off | -202.55%-11.76M | 7,642.11%11.46M | 89.58%-261K | 1,050.33%12.02M | 190.87%4.81M | -1,371.76%-5.11M | -100.85%-152K | -143.33%-2.5M | -75.02%1.05M | -69.88%1.65M |
| Other non-operating income (expenses) | -122,572.73%-94.3M | -78.43%77K | -99.28%2K | 0 | -98.70%1K | 7,300.00%74K | 5,000.00%357K | 27,600.00%277K | 0.00%2K | 7,600.00%77K |
| Income before tax | 83.51%-55.2M | -541.20%-334.79M | -134.66%-11.96M | -911.84%-250.64M | -38.37%-35.32M | -1.20%-36.87M | -88.20%-52.21M | 250.51%34.51M | -363.96%-24.77M | -310.10%-25.52M |
| Income tax | -46.81%7.09M | 63.03%13.32M | -150.86%-4.63M | 1,162.52%9.73M | 18.34%5.15M | 150.69%3.07M | 1,657.20%8.17M | 15,080.00%9.11M | 305.79%771K | 3,927.78%4.35M |
| Net income | 82.11%-62.28M | -476.49%-348.11M | -128.86%-7.33M | -919.40%-260.38M | -35.45%-40.46M | -31.50%-39.94M | -114.07%-60.39M | 210.49%25.4M | -361.96%-25.54M | -348.11%-29.87M |
| Net income continuous operations | 82.11%-62.28M | -476.50%-348.11M | -128.86%-7.33M | -919.41%-260.38M | -35.45%-40.46M | -31.49%-39.94M | -114.07%-60.38M | 210.50%25.41M | -361.96%-25.54M | -348.11%-29.87M |
| Noncontrolling interests | 160.73%18.88M | -3,085.55%-31.09M | -11.65%7.06M | -14,498.64%-42.33M | 183.62%3.75M | 108.96%428K | -214.82%-976K | 840.35%7.99M | 294K | -4.49M |
| Net income attributable to the company | 74.40%-81.17M | -433.63%-317.02M | -182.67%-14.39M | -743.95%-218.04M | -74.17%-44.22M | -57.71%-40.37M | -104.44%-59.41M | 173.02%17.41M | -367.28%-25.84M | -310.85%-25.39M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 74.40%-81.17M | -433.63%-317.02M | -182.67%-14.39M | -743.95%-218.04M | -74.17%-44.22M | -57.71%-40.37M | -104.44%-59.41M | 173.02%17.41M | -367.28%-25.84M | -310.85%-25.39M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 74.51%-2.62 | -429.90%-10.28 | -182.14%-0.46 | -741.67%-7.07 | -72.29%-1.43 | -59.04%-1.32 | -90.20%-1.94 | 167.47%0.56 | -320.00%-0.84 | -288.64%-0.83 |
| Diluted earnings per share | 74.51%-2.62 | -429.90%-10.28 | -183.25%-0.4662 | -739.37%-7.07 | -72.55%-1.4321 | -59.04%-1.32 | -90.20%-1.94 | 167.47%0.56 | -321.15%-0.8423 | -290.00%-0.83 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |